Meridian Bioscience Reports First Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance

Go back to Meridian Bioscience Reports First Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance

Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.3% Yield

January 27, 2016 7:34 AM EST

Meridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.20 per share, or $0.8 annualized.

The dividend will be payable on February 18, 2016, to stockholders of record on February 8, 2016, with an ex-dividend date of February 4, 2016.

The annual yield on the dividend is 4.3 percent.

For... More

Meridian Bioscience (VIVO) Reports In-Line Q1 EPS

January 27, 2016 7:34 AM EST

Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $48.6 million.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.

... More